Mounjaro
NDC 0002-3466 · Eli Lilly and Company
Generic nametirzepatide
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)TIRZEPATIDE
Strength4.17 mg/mL
Pharmacologic classG-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
Marketing categoryNDA
Packages
0002-3466-11 — 1 SYRINGE in 1 CARTON (0002-3466-11) / 2.4 mL in 1 SYRINGE (0002-3466-01)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0002-2471 — tirzepatide, 0002-2484 — tirzepatide, 0002-2495 — tirzepatide, 0002-2506 — tirzepatide, 0002-3002 — tirzepatide, 0002-3411 — tirzepatide, 0002-3422 — tirzepatide, 0002-3433 — tirzepatide, 0002-3444 — tirzepatide, 0002-3455 — tirzepatide, 0002-3511 — tirzepatide, 0002-3522 — tirzepatide, 0002-3533 — tirzepatide, 0002-3544 — tirzepatide, 0002-3555 — tirzepatide, 0002-3566 — tirzepatide, 0002-4052 — tirzepatide, 0002-4103 — tirzepatide, 0002-4210 — tirzepatide, 0002-4304 — tirzepatide, +33 more